181 related articles for article (PubMed ID: 33273801)
1. Role of
Gupta S; Martin LM; Sinha NR; Smith KE; Sinha PR; Dailey EM; Hesemann NP; Mohan RR
Mol Vis; 2020; 26():742-756. PubMed ID: 33273801
[TBL] [Abstract][Full Text] [Related]
2. Decorin transfection suppresses profibrogenic genes and myofibroblast formation in human corneal fibroblasts.
Mohan RR; Gupta R; Mehan MK; Cowden JW; Sinha S
Exp Eye Res; 2010 Aug; 91(2):238-45. PubMed ID: 20546727
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of corneal myofibroblast development through nanoparticle-mediated soluble transforming growth factor-β type II receptor (sTGFβRII) gene transfer.
Sharma A; Rodier JT; Tandon A; Klibanov AM; Mohan RR
Mol Vis; 2012; 18():2598-607. PubMed ID: 23112572
[TBL] [Abstract][Full Text] [Related]
4. Thrombin alters the synthesis and processing of CYR61/CCN1 in human corneal stromal fibroblasts and myofibroblasts through multiple distinct mechanisms.
Andreae EA; Warejcka DJ; Twining SS
Mol Vis; 2020; 26():540-562. PubMed ID: 32818017
[TBL] [Abstract][Full Text] [Related]
5. Modulation of human corneal stromal cell differentiation by hepatocyte growth factor and substratum compliance.
Miyagi H; Jalilian I; Murphy CJ; Thomasy SM
Exp Eye Res; 2018 Nov; 176():235-242. PubMed ID: 30193807
[TBL] [Abstract][Full Text] [Related]
6. Myofibroblast differentiation of normal human keratocytes and hTERT, extended-life human corneal fibroblasts.
Jester JV; Huang J; Fisher S; Spiekerman J; Chang JH; Wright WE; Shay JW
Invest Ophthalmol Vis Sci; 2003 May; 44(5):1850-8. PubMed ID: 12714615
[TBL] [Abstract][Full Text] [Related]
7. ITF2357 transactivates Id3 and regulate TGFβ/BMP7 signaling pathways to attenuate corneal fibrosis.
Lim RR; Tan A; Liu YC; Barathi VA; Mohan RR; Mehta JS; Chaurasia SS
Sci Rep; 2016 Feb; 6():20841. PubMed ID: 26865052
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors blocked activation and caused senescence of corneal stromal cells.
Zhou Q; Wang Y; Yang L; Wang Y; Chen P; Wang Y; Dong X; Xie L
Mol Vis; 2008; 14():2556-65. PubMed ID: 19122829
[TBL] [Abstract][Full Text] [Related]
9. Corneal fibrosis abrogation by a localized AAV-mediated inhibitor of differentiation 3 (Id3) gene therapy in rabbit eyes in vivo.
Gupta S; Fink MK; Kempuraj D; Sinha NR; Martin LM; Keele LM; Sinha PR; Giuliano EA; Hesemann NP; Raikwar SP; Chaurasia SS; Mohan RR
Mol Ther; 2022 Oct; 30(10):3257-3269. PubMed ID: 35780298
[TBL] [Abstract][Full Text] [Related]
10. Latrunculin B and substratum stiffness regulate corneal fibroblast to myofibroblast transformation.
Thomasy SM; Raghunathan VK; Miyagi H; Evashenk AT; Sermeno JC; Tripp GK; Morgan JT; Murphy CJ
Exp Eye Res; 2018 May; 170():101-107. PubMed ID: 29421383
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Inhibitor of differentiation (Id) proteins in human cornea.
Mohan RR; Morgan BR; Anumanthan G; Sharma A; Chaurasia SS; Rieger FG
Exp Eye Res; 2016 May; 146():145-153. PubMed ID: 26712606
[TBL] [Abstract][Full Text] [Related]
12. Inhibitor of differentiation 1 (Id1) and Id3 proteins play different roles in TGFβ effects on cell proliferation and migration in prostate cancer cells.
Strong N; Millena AC; Walker L; Chaudhary J; Khan SA
Prostate; 2013 May; 73(6):624-33. PubMed ID: 23060149
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of epithelial basement membrane components nidogens and perlecan in corneal stromal cells in vitro.
Santhanam A; Torricelli AA; Wu J; Marino GK; Wilson SE
Mol Vis; 2015; 21():1318-27. PubMed ID: 26788024
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of CRISPR/Cas9 mediated TGIF gene editing to inhibit corneal fibrosis in vitro.
Tripathi R; Sinha NR; Kempuraj D; Balne PK; Landreneau JR; Juneja A; Webel AD; Mohan RR
Exp Eye Res; 2022 Jul; 220():109113. PubMed ID: 35588782
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta-3 localization in the corneal response to epithelial-stromal injury and effects on corneal fibroblast transition to myofibroblasts.
Shiju TM; Sampaio LP; Martinez VV; Hilgert GSL; Wilson SE
Exp Eye Res; 2023 Oct; 235():109631. PubMed ID: 37633325
[TBL] [Abstract][Full Text] [Related]
16. Stromal fibroblast-bone marrow-derived cell interactions: implications for myofibroblast development in the cornea.
Singh V; Agrawal V; Santhiago MR; Wilson SE
Exp Eye Res; 2012 May; 98(1):1-8. PubMed ID: 22465408
[TBL] [Abstract][Full Text] [Related]
17. Corneal myofibroblast viability: opposing effects of IL-1 and TGF beta1.
Kaur H; Chaurasia SS; Agrawal V; Suto C; Wilson SE
Exp Eye Res; 2009 Aug; 89(2):152-8. PubMed ID: 19285499
[TBL] [Abstract][Full Text] [Related]
18. Induction of corneal myofibroblasts by lens-derived transforming growth factor beta1 (TGFbeta1): a transgenic mouse model.
Reneker LW; Bloch A; Xie L; Overbeek PA; Ash JD
Brain Res Bull; 2010 Feb; 81(2-3):287-96. PubMed ID: 19897021
[TBL] [Abstract][Full Text] [Related]
19. Effects of TGFβ1, PDGF-BB, and bFGF, on human corneal fibroblasts proliferation and differentiation during stromal repair.
Gallego-Muñoz P; Ibares-Frías L; Valsero-Blanco MC; Cantalapiedra-Rodriguez R; Merayo-Lloves J; Martínez-García MC
Cytokine; 2017 Aug; 96():94-101. PubMed ID: 28390267
[TBL] [Abstract][Full Text] [Related]
20. A selective inhibitor of the Rho kinase pathway, Y-27632, and its influence on wound healing in the corneal stroma.
Yamamoto M; Quantock AJ; Young RD; Okumura N; Ueno M; Sakamoto Y; Kinoshita S; Koizumi N
Mol Vis; 2012; 18():1727-39. PubMed ID: 22815626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
